---
title: Metabolomic profiling for dyslipidemia in pediatric patients with sickle cell
  disease, on behalf of the IHCC consortium
date: '2022-12-02'
linkTitle: http://link.springer.com/10.1007/s11306-022-01954-z
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Previous
  study has shown that dyslipidemia is common in patients with Sickle cell disease
  (SCD) and is associated with more serious SCD complications.</p> </span> <span class="a-plus-plus
  abstract-section id-a-sec2"> <h3 class="a-plus-plus">Methods</h3> <p class="a-plus-plus">This
  study investigated systematically dyslipidemia in SCD using a state-of-art nuclear
  magnetic resonance (NMR) metabolomics platform, including 147 pediatric cases ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Previous study has shown that dyslipidemia is common in patients with Sickle cell disease (SCD) and is associated with more serious SCD complications.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 class="a-plus-plus">Methods</h3> <p class="a-plus-plus">This study investigated systematically dyslipidemia in SCD using a state-of-art nuclear magnetic resonance (NMR) metabolomics platform, including 147 pediatric cases ...